Peter Sleight - Concepedia

Author

Peter Sleight

Also Known As

B Mihaylova, Barry Davis, David Simpson, Douglas D DeCarolis, G Dagenais, J. Tobert, Mabyn Ross, Nicole Soranzo, P J Sleight, P SLEIGHT

622

Publications

73.9K

Citations

104

H-Index

219

Concepts

All Affiliations

John Radcliffe Hospital University of Oxford McMaster University Population Health Research Institute University of Pavia

About

Peter Sleight is an author at John Radcliffe Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	32	46	5.7K
2	Education	3	3	285
3	Engineering	3	3	84
4	Arts	2	2	30
5	Language Studies	1	1	22

Peter Sleight

257

Publications

63.6K

Citations

H-Index

Page 1

	Year	Citations
2013 ESH/ESC Guidelines for the management of arterial hypertension Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, European Heart Journal	2013	13.6K
2013 ESH/ESC Guidelines for the management of arterial hypertension Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, Journal of Hypertension	2013	5.6K
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS Robert Altman, L Carreras, Rubén Sierra Díaz, Oxford University Research Archive (ORA) (University of Oxford) ThrombosisIschemic StrokeCardiovascular DiseaseMedicineBlood Platelet	1994	3.3K
Beta blockade during and after myocardial infarction: An overview of the randomized trials Salim Yusuf, Richard Peto, John A. Lewis, Progress in Cardiovascular Diseases Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseClinical TrialsRandomized Trials	1985	3.2K
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. R B Sleight, Peter Sleight, Sarah Parish, PubMed	1988	2.9K
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Colin Baigent, Martin Landray, Christina Reith, The Lancet Cardiovascular DiseaseMedicineAntihypertensive TherapyHyperlipidemiaLdl Cholesterol	2011	2.4K
Reflex Regulation of Arterial Pressure during Sleep in Man Harley S. Smyth, Peter Sleight, George Pickering Circulation Research Sleep DisordersHypertensionPressure MeasurementBlood Pressure VariabilityPressure Rise	1969	1.3K
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, Journal of Hypertension HypertensionEsh/esc GuidelinesClinical GuidelinesPreventive CardiologyBlood Pressure	2013	1.2K
ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction. Robert T. Collins, R Peto, Marcus Flather, Ghent University Academic Bibliography (Ghent University) ThrombosisCardiovascular DiseasePharmacotherapyIntravenous Magnesium SulphateEarly Oral Captopril	1995	1.1K
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions Rory Collins, Jane Armitage, Sarah Parish, The Lancet ThrombosisVascular DiseaseIschemic StrokeCardiovascular DiseaseMedicine	2004	1.1K

Page 1